Roche Strengthen the Role of Modeling and Simulation

Roche Strengthen the Role of Modeling and Simulation in Clinical Drug Development - Five Main Reasons to Join Us - Mid-2007 Roche introduced a new organization allowing a more proactive role of M&S across the value chain of clinical development. The M&S group belongs to a new science department: Methodology & Innovation (M&I) which ensures that leading-edge methods are applied in such areas as modeling and simulation (M&S), biostatistics, translation medicine and experimental medicine High expectation and full support from the head of Pharma Development on the impact of M&S with the following vision: "A model-based drug development" High visibility with a Disease Area M&S Experts in direct contact with each of the five Disease Area Leadership Teams which manage the compounds from drug discovery through to medical proof of concept, with oversight through to the market Increase in efficiency with a programming support for dataset building and graphical analyses Increase in capacity with 7 M&S positions opened in the US (Nutley, NJ and Palo-Alto, CA): 1 management position (local Head), 5 pharmacometrician positions and 2 entry level positions Please send all update CV's to [EMAIL PROTECTED] Kevin Smith Staffing Consultant 650-855-6349 [EMAIL PROTECTED] <<image001.png>>